Fully automated quantification of hepatitis C virus (HCV) RNA in human plasma and human serum by the COBAS® AmpliPrep/COBAS® TaqMan® System
- 30 April 2007
- journal article
- research article
- Published by Elsevier in Journal of Clinical Virology
- Vol. 38 (4), 326-333
- https://doi.org/10.1016/j.jcv.2006.12.021
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Hepatitis C Virus Serologic and Virologic Tests and Clinical Diagnosis of HCV-Related Liver DiseaseInternational Journal of Medical Sciences, 2006
- Dynamic Range of Hepatitis C Virus RNA Quantification with the Cobas Ampliprep-Cobas Amplicor HCV Monitor v2.0 AssayJournal of Clinical Microbiology, 2005
- The Natural History of Hepatitis CSeminars in Liver Disease, 2004
- Prediction of Treatment Outcome in Patients With Chronic Hepatitis C: Significance of Baseline Parameters and Viral Dynamics During TherapyHepatology, 2003
- Course and outcome of hepatitis CHepatology, 2002
- Monitoring of viral levels during therapy of hepatitis CHepatology, 2002
- First phase viral kinetic parameters as predictors of treatment response and their influence on the second phase viral declineJournal of Viral Hepatitis, 2002
- Automation of laboratory testing for infectious diseases using the polymerase chain reaction — our past, our present, our futureJournal of Clinical Virology, 2001
- Performance of the COBAS AMPLICOR HCV MONITOR Test, Version 2.0, an Automated Reverse Transcription-PCR Quantitative System for Hepatitis C Virus Load DeterminationJournal of Clinical Microbiology, 2000
- Loss of serum HCV RNA at week 4 of interferon-α therapy is associated with more favorable long-term response in patients with chronic hepatitis CJournal of Medical Virology, 1995